Literature DB >> 11118029

Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B.

S Nejentsev1, Z Gombos, A P Laine, R Veijola, M Knip, O Simell, O Vaarala, H K Akerblom, J Ilonen.   

Abstract

Several studies provide evidence that in addition to the DQ-DR genes, HLA contains another uncharacterized gene or genes associated with type 1 diabetes. Our aim was to investigate the effect of this gene independently of the DQ-DR genes and to localize it with a matched case-control study. More than 1,400 patients and 30,000 control individuals from Finland were studied. They were first genotyped for the selected alleles of the HLA-DQB1, -DQA1, and -DRB1 genes. For the DR3/4(0404) genotype, 75 patients and 181 control subjects were stratified, and 241 patients and 354 controls were stratified for the DR3/4(0401) genotype. Ten microsatellite markers in the HLA class III and I regions (D6S273, TNFa, C12A, STR MICA, MIB, C125, C143, C245, C3211, and MOGc) and selected alleles of the HLA-A and HLA-B genes were studied. In the DR3/4(0404)-stratified group, we found that markers located between C12A and C143 near the HLA-B gene confer a strong additional diabetes association. This was confirmed by the population differentiation test in both DR3/4(0404)- and DR3/4(0401)-stratified groups. Our data indicate that an additional gene associated with type 1 diabetes is located in the 240-kb region near HLA-B. We excluded STR MICA polymorphism as a mutation responsible for diabetes association.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118029     DOI: 10.2337/diabetes.49.12.2217

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes.

Authors:  Heather J Cordell; David G Clayton
Journal:  Am J Hum Genet       Date:  2001-11-21       Impact factor: 11.025

2.  Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease.

Authors:  Ainhoa Martín-Pagola; Lourdes Ortiz; Gustavo Pérez de Nanclares; Juan Carlos Vitoria; Luis Castaño; J Ramón Bilbao
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.317

3.  Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC.

Authors:  Yee Him Cheung; John Watkinson; Dimitris Anastassiou
Journal:  Hum Genet       Date:  2010-11-14       Impact factor: 4.132

4.  Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes.

Authors:  R Hermann; K Lipponen; M Kiviniemi; T Kakko; R Veijola; O Simell; M Knip; J Ilonen
Journal:  Diabetologia       Date:  2006-04-14       Impact factor: 10.122

5.  Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes.

Authors:  M C Eike; K Humphreys; T Becker; M Olsson; B A Lie
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

6.  Association analysis of SNPs in the IL4R locus with type I diabetes.

Authors:  H A Erlich; K Lohman; S J Mack; A M Valdes; C Julier; D Mirel; J A Noble; G E Morahan; S S Rich
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

7.  Evidence for association of the TCF7 locus with type I diabetes.

Authors:  H A Erlich; A M Valdes; C Julier; D Mirel; J A Noble
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

8.  The type 1 diabetes - HLA susceptibility interactome--identification of HLA genotype-specific disease genes for type 1 diabetes.

Authors:  Caroline Brorsson; Niclas Tue Hansen; Regine Bergholdt; Søren Brunak; Flemming Pociot
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

9.  Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.

Authors:  I Santin; A Castellanos-Rubio; A M Aransay; G Gutierrez; S Gaztambide; I Rica; J L Vicario; J A Noble; L Castaño; J R Bilbao
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

10.  HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.

Authors:  Henry Erlich; Ana Maria Valdes; Janelle Noble; Joyce A Carlson; Mike Varney; Pat Concannon; Josyf C Mychaleckyj; John A Todd; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Priscilla Moonsamy
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.